Ba Yi

1 clinical trials · Sponsor

Record	Firm	Date
Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma (NCT06430827)	Ba Yi	2024-06-30

Every clearance here is in the API, with alerts when new ones post.